AGTC Catapults Premarket on $1 Billion+ Eye Disease Pact With Biogen

AGTC Catapults Premarket on $1 Billion+ Eye Disease Pact With Biogen CAMBRIDGE, Mass. — Biogen, Inc. and AGTC (AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, entered into an agreement worth more than $1 billion to develop gene-based therapies for multiple ophthalmic diseases, the two companies announced this morning. ... Read More »

Stay grounded :: When you fly high

Stay grounded :: When you fly high Father is flying a kite. His son is watching him carefully. After some time son says “Dad. Because of the string the kite is not able to go any further higher.” Hearing this, the father smiles and breaks the string.     The kite goes higher after breaking of the thread and then ... Read More »

Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m

Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m Swiss drugmaker Novartis has strengthened its presence in pain management by agreeing to acquire a US-Australia biotech firm Spinifex Pharmaceuticals for more than $200m. Spinifex is focused on developing a peripheral approach to treat neuropathic pain such as EMA401, a new angiotensin II Type 2 receptor (AT2R) antagonist. EMA401 is ... Read More »

Siemens, BioNTech to develop new personalized cancer vaccines

Siemens, BioNTech to develop new personalized cancer vaccines Siemens has entered into a strategic collaboration with BioNTech for the good manufacturing practice (GMP) production of personalized cancer vaccines. Under the deal, BioNTech’s subsidiaries, BioNTech RNA Pharmaceuticals and EUFETS, will work with Siemens to build a fully automated and digitalized production site to provide capacity for BioNTech’s personalized cancer vaccines to ... Read More »

Hesitation… And why should we avoid it…

Hesitation… And why should we avoid it… Neil Armstrong, he is the 1st person to set his foot in moon. But, do you know who was supposed to be the 1st person?  Many don’t know… His name is Edwin C Aldarin… He was the pilot for the Apollo mission. He was working for the American Airforce. Moreover he had experience ... Read More »

A Management Lesson

A Management Lesson……… One fine day, a bus driver went to the bus garage, started his bus, and drove off along the route. No problems for the first few stops-a few people got on, a few got off, and things went generally well. At the next stop, however, a big hulk of a guy got on. Six feet eight, built ... Read More »

AbCheck and Pierre Fabre Enter Into Strategic Research Partnership

AbCheck and Pierre Fabre Enter Into Strategic Research Partnership  AbCheck s.r.o, a wholly owned subsidiary of Affimed N.V., Heidelberg, Germany, and Pierre Fabre Pharmaceuticals have expanded their ongoing collaboration into a strategic research partnership in the field of human antibody discovery and optimization. Under the expanded agreement, AbCheck will use its proprietary human antibody discovery and optimization platform technologies, AbSieve ... Read More »

It’s all about acceptance and attitude

It’s all about acceptance and attitude What is fear? Unacceptance of uncertainty. If we accept that uncertainty. It becomes  …….Adventure! What is envy? Unacceptance of good in others If we accept that good . It becomes ……..inspiration! What is Anger? Unacceptance of things which are beyond our control. If we accept….. It becomes …..Tolerance! What is hatred? Unacceptance of person ... Read More »

SPARC licenses Xelpros to Sun Pharma for US market

SPARC licenses Xelpros to Sun Pharma for US market Sun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the US market. In addition to up-front payment of USD 3 million, SPARCBSE 2.83 % will receive certain other milestone payments, both totaling to USD 16 million from Sun Pharma, ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes